Population
300 women, including 240 with Polycystic Ovary Syndrome according to the Rotterdam criteria and 60 controls…
Design
Cross-sectional
Authors
Loading...
Does not change CVD risk assessment in PCOS; leaves open Lp-PLA2 utility in classic phenotypes.
Only the two classic Rotterdam phenotypes of PCOS exhibit excess cardiometabolic risk, suggesting that targeted treatment is needed to prevent CVD events in these specific subgroups.
Δασκαλόπουλος et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: